This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to define the role of iron homeostasis in the responses of proximal tubular epithelial cells to kidney fibrosis, which is a key driver of chronic kidney disease (CKD) progression. The $199,922 award to Weill Medical College of Cornell University will support experiments to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $225,000 to investigate the role of the protein α-synuclein in regulating the erythroid iron restriction response. The research aims to elucidate how α-synuclein and the neurotransmitter dopamine modulate erythropoiesis during iron deficiency, which can lead to iron deficiency anemia....
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $516,648 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially derived metabolites regulate host gut inflammation. The award period runs from August 28, 2024 to February 28, 2027. The research aims to determine the regulatory...
This Project Grant award of $1,560,024 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 supports research on the intracellular trafficking and signaling of the metabolite heme in myeloid cells. The primary awardee, Scripps Research Institute, will leverage mouse models, chemical tools, and new mouse mutants to reveal a molecular pathway for how heme signaling regulates the differentiation and function of macrophages under normal and disease...
This federal Project Grant award of $151,643, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on developing and evaluating Proteolysis Targeting Chimeras (PROTACs) to stabilize hypoxia-inducible factors (HIFs) as a potential therapeutic approach for inflammatory bowel disease (IBD). The principal investigator, Dr. Ornelas Sanchez, and his...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will provide $532,177.00 to The University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct research on a new inflammation pathway in diabetic kidney disease (DKD). The key objectives are to: Investigate how the transcription modulator I-MFA stimulates inflammatory cytokine production and secretion by...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) provides $1,739,177 to The Leland Stanford Junior University to conduct research on the role of impaired cellular RNA editing in the etiology of inflammatory bowel disease (IBD). The research aims to: Leverage genetic data to prioritize double-stranded RNA (dsRNA) loci associated with IBD susceptibility and systematically assess how risk and protective alleles affect dsRNA editing....
The University of North Carolina at Greensboro received a $894,330 Project Grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to study the effect of almond consumption on iron status in inflammatory states. The grant supports research from August 15, 2022 to July 31, 2025 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), which aims to promote biomedical research improving understanding and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $497,370 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Regents of the University of Michigan. The grant, titled "CD45 MEDIATED REGULATION OF PMN FUNCTION DURING INTESTINAL INFLAMMATION", will fund research to determine the effects of neutrophil-specific loss of the CD45 tyrosine phosphatase on intestinal inflammation and repair processes. The...
This $400,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the earliest events in podocyte injury in collagen IV nephropathies. The goal is to investigate how processing of mutant collagen IV proteins injures podocytes at early stages, leading to chronic kidney disease and renal failure. The research uses...